Education
About Us
Working with TipRanks
Follow Us
Neurocrine Biosciences (DE:NB3)
:NB3
Neurocrine (NB3) Ownership Overview
1.09% Insiders
25.67%
Mutual Funds
6.47% Other Institutional Investors
28.80% ETFs
37.97% Public Companies and Individual Investors
The ownership structure of Neurocrine (DE:NB3) stock is a mix of institutional, retail, and individual investors. Approximately 60.94% of the company’s stock is owned by Institutional Investors, 1.09% is owned by Insiders, and 37.97% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
Feb 14, 2025 | xxxxxxxxxxxxx | $57520 | |
Aug 16, 2024 | xxxxxxxxxxxxx | $2090333 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
Mar 31, 2025 | xxxxxxxxxxxxx | $120443 | |
Mar 31, 2025 | xxxxxxxxxxxxx | $289661 | |
Mar 31, 2025 | xxxxxxxxxxxxx | $2787120 | |
Mar 31, 2025 | xxxxxxxxxxxxx | $9648522 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 11,459,831 | Institution | 11.58% | 1,329,523,753 | |
| 9,374,506 | Institution | 9.47% | 1,087,592,688 | |
| 8,754,959 | Institution | 8.85% | 1,015,715,323 | |
| 3,016,425 | Institution | 3.05% | 349,953,563 | |
| 2,843,069 | Institution | 2.87% | 329,841,493 | |
| 2,341,850 | Institution | 2.37% | 271,692,070 | |
| 1,006,719 | Institution | 1.02% | 116,795,512 | |
| 862,000 | Institution | 0.87% | 100,005,792 | |
| 734,141 | Institution | 0.74% | 85,172,102 | |
| 698,448 | Institution | 0.71% | 81,031,143 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 8,754,959 | Institution | 8.85% | 1,015,715,323 | |
| 2,341,850 | Institution | 2.37% | 271,692,070 | |
| 1,006,719 | Institution | 1.02% | 116,795,512 | |
| 734,141 | Institution | 0.74% | 85,172,102 | |
| 619,255 | Institution | 0.63% | 71,843,488 | |
| 541,899 | Institution | 0.55% | 62,868,954 | |
| 535,613 | Institution | 0.54% | 62,139,678 | |
| 522,516 | Institution | 0.53% | 60,620,216 | |
| 499,606 | Institution | 0.50% | 57,962,290 | |
| 444,935 | Institution | 0.45% | 51,619,579 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|
FAQ
Who Owns Neurocrine Biosciences (DE:NB3)?
According to the latest TipRanks data, approximately 6.47% of the company's stock is held by institutional investors, 1.09% is held by insiders, and 37.97% is held by retail investors.
What percentage of Neurocrine Biosciences (DE:NB3) stock is held by institutional investors?
According to the latest TipRanks data, approximately 6.47% of Neurocrine Biosciences (DE:NB3) stock is held by institutional investors.
What percentage of Neurocrine Biosciences (DE:NB3) stock is held by retail investors?
According to the latest TipRanks data, approximately 37.97% of Neurocrine Biosciences (DE:NB3) stock is held by retail investors.
Who owns the most shares of Neurocrine Biosciences (DE:NB3)?
iShares owns the most shares of Neurocrine Biosciences (DE:NB3).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.